Page last updated: 2024-08-24

gemcitabine and Cancer Syndromes, Hereditary

gemcitabine has been researched along with Cancer Syndromes, Hereditary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Junghanss, C; Maletzki, C; Nassar, I; Stenzel, J; Wiegele, L	1

Other Studies

1 other study(ies) available for gemcitabine and Cancer Syndromes, Hereditary

Article	Year
Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer. Journal for immunotherapy of cancer, 2019, 01-10, Volume: 7, Issue:1 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cancer Vaccines; Cell Line, Tumor; Colorectal Neoplasms; Cyclophosphamide; Dendritic Cells; Deoxycytidine; Gastrointestinal Neoplasms; Gemcitabine; Immunotherapy; Mice; Myeloid-Derived Suppressor Cells; Neoplastic Syndromes, Hereditary; Spleen; T-Lymphocytes, Regulatory	2019

Article

Year

Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer.

Journal for immunotherapy of cancer, 2019, 01-10, Volume: 7, Issue:1

Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cancer Vaccines; Cell Line, Tumor; Colorectal Neoplasms; Cyclophosphamide; Dendritic Cells; Deoxycytidine; Gastrointestinal Neoplasms; Gemcitabine; Immunotherapy; Mice; Myeloid-Derived Suppressor Cells; Neoplastic Syndromes, Hereditary; Spleen; T-Lymphocytes, Regulatory

2019